Physician profile
Traci Motes
NPI 1598167868
$1,663.38
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $159 · 2023: $1,224 · 2024: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,397 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,397.27 |
| Education | $106.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $381.92 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $220.42 | 2023-2024 | Fasenra |
| Melinta Therapeutics, LLC | $185.82 | 2023 | Rezzayo, Orbactiv |
| Alexion Pharmaceuticals, INC. | $162.62 | 2023-2024 | Ultomiris |
| Idorsia Pharmaceuticals US INC | $112.90 | 2023 | Quviviq |
| Amgen INC. | $111.03 | 2023 | Otezla |
| Janssen Scientific Affairs, LLC | $106.61 | 2023 | Xarelto |
| Alnylam Pharmaceuticals INC. | $101.39 | 2022 | |
| Grifols USA, LLC | $99.06 | 2023 | Prolastin-C Liquid |
| Dexcom, INC. | $78.89 | 2023 | Dexcom G6 Transmitter |
| Grt US Holding, INC. | $57.73 | 2022 | |
| Astellas Pharma US INC | $44.99 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Traci Motes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.